Here's the translation:

BioDAO has launched Long COVID Labs (COVID), a project designed to revolutionize the medicine industry. This project was launched as the 63rd project of Binance Launchpool.

The goal of Long COVID Labs is to understand the long-term effects of COVID-19 and develop treatments for them. According to the project, about 20% of patients who have recovered from COVID-19 still have viral remnant Spike protein substances in their blood. Additionally, about 40% of patients struggling with long COVID are experiencing chronic diseases.

The vision of Long COVID Labs is to develop treatments for long COVID and change the medicine industry. The project's founders include Rohan Dixit, Ruth Ann Crystal (MD), Jacob Glenville, and Annelise Barron.

Long COVID Labs operates on a DAO (Decentralized Autonomous Organization) model, where users/patients receive governance tokens (COVID) that enable them to vote on proposals, recommend funding for research, and supervise funds.

There are two ways to obtain COVID tokens:

1. Through research: Users can earn COVID tokens by participating in research.

2. Through stakeholders: Stakeholders can purchase COVID tokens directly and provide funding for research.

Summary:

- Long COVID Labs (COVID) has been launched by BioDAO.

- The project aims to understand the long-term effects of COVID-19 and develop treatments for them.

- The project operates on a DAO model, where users/patients receive governance tokens (COVID).

- COVID tokens can be obtained through research or by stakeholders.

#BIOProtocol #COVID $BIO #CryptoMarketDip #NewsAboutCrypto #USJoblessClaimsDrop